F. Hedborg et al., IGF2 EXPRESSION IS A MARKER FOR PARAGANGLIONIC SIF CELL-DIFFERENTIATION IN NEUROBLASTOMA, The American journal of pathology, 146(4), 1995, pp. 833-847
Neuroblastoma is a childhood tumor of the sympathetic nervous system O
bservations in the Beckwith-Wiedemann syndrome suggest that sympatheti
c embryonal cells with an abundant expression of the insulin-like grow
th factor 2 gene (IGF2) may be involved in the genesis of low malignan
t infant neuroblastomas. We have therefore compared the cell type-spec
ific IGF2 expression of the human sympathetic nervous system during ea
rly development with that of neuroblastoma. An abundant expression in
normal sympathetic tissue was specific to extra-adrenal chromaffin cel
ls, ie, paraganglia and small intensely fluorescent (SIF) cells, where
as sympathetic neuronal cells were IGF2-negative. A subpopulation of n
euroblastomas expressed IGF2, which correlated with an early age at di
agnosis, an extraadrenal tumor origin, and severe hemodynamic signs of
catecholamine secretion. Histologically IGF2-expressing tumors displa
yed a lobular growth pattern, and expression was restricted to the mos
t mature and least proliferative cells. Typically, these cells were mo
rphologically and histochemically similar to paraganglia/SIF cells and
formed distinct ring-like zones in the center of the lobules around a
core of apoptosis-like tumor cells. The similarities found between IG
F2-expressing neuroblastoma cells and paraganglia/SIF cells in terms o
f histological features, anatomical origin, and age-dependent growth s
uggest a paraganglionic/SIF cell lineage of most infant tumors and als
o of extra-adrenal tumors diagnosed after infancy. Furthermore, since
paraganglia/SIF cells undergo postnatal involution, the same cellular
mechanism may be responsible for spontaneous regression in infant neur
oblastoma.